INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$3.6M

$3,596,020

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
TARS S Tarsus Pharmaceuticals, Inc. Neervannan Seshadri • COO 10b5-1 SellΔOwn -10.6% 2026-03-04 $641,421 View Form 4 →
TARS	Tarsus Pharmaceuticals, Inc.	Neervannan Seshadri COO 10b5-1 SellΔOwn -10.6%	2026-03-04	$641,421	S	Form 4
TARS S Tarsus Pharmaceuticals, Inc. Lin Elizabeth Yeu • Officer • Chief Medical Officer Sell to Cover 2025-12-16 $165,201 View Form 4 →
TARS	Tarsus Pharmaceuticals, Inc.	Lin Elizabeth Yeu Officer • Chief Medical Officer Sell to Cover	2025-12-16	$165,201	S	Form 4
TARS S Tarsus Pharmaceuticals, Inc. Whitfield Dianne C. • Officer • Chief Human Resources Officer 10b5-1 SellΔOwn -16.0% 2025-12-16 $592,500 View Form 4 →
TARS	Tarsus Pharmaceuticals, Inc.	Whitfield Dianne C. Officer • Chief Human Resources Officer 10b5-1 SellΔOwn -16.0%	2025-12-16	$592,500	S	Form 4
TARS S Tarsus Pharmaceuticals, Inc. LINK WILLIAM J PHD • Director 10b5-1 Sell 2025-12-15 $1,864,678Largex5 View Form 4 →
TARS	Tarsus Pharmaceuticals, Inc.	LINK WILLIAM J PHD Director 10b5-1 Sell	2025-12-15	$1,864,678Largex5	S	Form 4
TARS S Tarsus Pharmaceuticals, Inc. Azamian Bobak R. • CEO 10b5-1 Sell 2025-09-24 $332,220 View Form 4 →
TARS	Tarsus Pharmaceuticals, Inc.	Azamian Bobak R. CEO 10b5-1 Sell	2025-09-24	$332,220	S	Form 4